Use of ACE Inhibitors and Angiotensin Receptor Blockers and Primary Breast Cancer Outcomes

BACKGROUND: ACE inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) may have anti-tumor properties. We investigated whether the use of ACEI/ARBs affects the clinical outcomes of primary breast cancer patients receiving taxane and anthracycline-based neoadjuvant chemotherapy. METHODS: We incl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chae, Young Kwang, Brown, Erika N., Lei, Xiudong, Melhem-Bertrandt, Amal, Giordano, Sharon H., Litton, Jennifer K., Hortobagyi, Gabriel N., Gonzalez-Angulo, Ana M., Chavez-MacGregor, Mariana
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2013
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3753529/
https://ncbi.nlm.nih.gov/pubmed/23983819
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.6888
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados